drugset / Trial / NCT00372723
Study of a Potential New Treatment for Patients With Toxic Epidermal Necrolysis (TEN)
Non-randomizedSingle-groupOpen-labelTreatment
Summary
To determine whether treatment of patients who have toxic epidermal necrolysis with a drug called remicaide increases the number of patients who are alive 30 days laters.
Timeline
- Start
- 2006-07
- Primary completion
- 2011-06
- Completion
- 2011-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Infliximab | Monoclonal antibody | 5 mg/kg | Intravenous |